Accolade Inc (STU:4NE1)
€ 3.42 0.12 (3.64%) Market Cap: 275.12 Mil Enterprise Value: 279.28 Mil PE Ratio: 0 PB Ratio: 0.70 GF Score: 61/100

Accolade Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2021 / 05:10PM GMT
Release Date Price: €31.6 (-4.24%)
Jailendra P. Singh;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. We'll get started here. I'm Jailendra Singh, health care technology and distribution analyst at Credit Suisse. Thanks, everyone, for joining us for this session. Next up, we have Accolade, and from the company, we have Raj Singh, CEO.

Accolade is a leader in personalized health benefit solutions with expanding capabilities in virtual primary care and expert opinions to help improve the experience, outcomes and cost of health care for employers. We are going to do this in a fireside chat format. I have some prepared questions, which I plan to cover, but if anyone from the audience has a question, please e-mail them to me at [email protected].

Raj, thank you so much for doing this. Really appreciate it.

Rajeev Singh
Accolade, Inc. - Chairman of the Board & CEO

Great to be here, Jailendra. Thanks for having me.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot